- Report
- March 2024
- 90 Pages
United States
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2024
- 135 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2024
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2024
- 110 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2023
- 90 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- September 2022
- 62 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- January 2023
- 103 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- November 2022
- 54 Pages
Global
- Report
- June 2021
- 77 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- October 2023
- 85 Pages
United States
From €4629EUR$4,850USD£3,878GBP
- Report
- January 2024
- 200 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- April 2023
- 305 Pages
Global
From €3340EUR$3,500USD£2,799GBP
€4772EUR$5,000USD£3,998GBP
- Report
- November 2023
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2023
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- June 2021
Global
From €2672EUR$2,800USD£2,239GBP
€3818EUR$4,000USD£3,199GBP
From €3340EUR$3,500USD£2,799GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3340EUR$3,500USD£2,799GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3340EUR$3,500USD£2,799GBP
From €3340EUR$3,500USD£2,799GBP
- Report
- February 2024
- 175 Pages
Global
From €4295EUR$4,500USD£3,598GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more